1. Cancer risk susceptibility loci in a Swedish population
    Wen Liu et al, 2017, Oncotarget CrossRef
  2. Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
    Sareh Kakavandi et al, 2023, Cell Communication and Signaling CrossRef
  3. Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR
    Glinton Hanover et al, 2023, Cell Reports CrossRef
  4. EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours
    Behzad M. Toosi et al, 2018, Oncogene CrossRef
  5. The EphB6 Receptor: Kinase-Dead but Very Much Alive
    Timothy G. Strozen et al, 2021, International Journal of Molecular Sciences CrossRef
  6. Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatment
    James M. Paul et al, 2016, Oncotarget CrossRef
  7. Structure of the EphB6 receptor ectodomain
    Emilia O. Mason et al, 2021, PLOS ONE CrossRef
  8. Erythropoietin-producing hepatocellular receptor B6 is highly expressed in non-functioning pituitary neuroendocrine tumors and its expression correlates with tumor size
    Hadara Rubinfeld et al, 2024, Molecular Biology Reports CrossRef
  9. Kinome scale profiling of venom effects on cancer cells reveals potential new venom activities
    Danielle McCullough et al, 2020, Toxicon CrossRef